Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
levomefolate calcium + methylcobalamin + pyridoxal phosphate
- Development stage
- Unknown
- Lead developer
- Vanprom Lifesciences
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
ZUEMETH-PLUS is an oral fixed-dose combination of three active B-vitamins: levomefolate calcium (the active form of vitamin B9), methylcobalamin (the active form of vitamin B12), and pyridoxal 5-phosphate (the active form of vitamin B6). Developed and marketed by Vanprom Lifesciences, this combination is approved for the management of diabetic peripheral neuropathy, peripheral neuropathy, hyperhomocysteinemia, and nutritional deficiencies. By providing these vitamins in their biologically active forms, ZUEMETH-PLUS bypasses the need for enzymatic conversion in the body, directly supporting nerve repair, reducing neuropathic pain, and lowering elevated homocysteine levels to protect cardiovascular and neurological health.
- Brand names
- ZUEMETH-PLUSZuemeth Plus
- Other names
- L-methylfolate calcium + methylcobalamin + pyridoxal 5-phosphatelevomefolate calcium + mecobalamin + pyridoxal phosphatelevomefolate calcium + methylcobalamin + pyridoxal 5-phosphate
02
Targets
CBS (Cystathionine beta-synthase)MTR (Methionine synthase)
Beyond the preview
Go deeper on levomefolate calcium + methylcobalamin + pyridoxal phosphate.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on levomefolate calcium + methylcobalamin + pyridoxal phosphate.